Skip to content

The application of artificial intelligence-based autofluorescence examination in potential malignant diseases of oral mucosa

The application of artificial intelligence-based autofluorescence examination in potential malignant diseases of oral mucosa

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108882
Enrollment
Unknown
Registered
2025-09-08
Start date
2025-09-15
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral potential malignant diseases

Interventions

Gold Standard:Pathological examination
Index test:Autofluorescence detection

Sponsors

Peking University Hospital of Stomatology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with oral cancer clinically and pathologically, as well as potential malignant diseases, including leukoplakia, erythema, lichenus planus, and oral submucosal fibrosis, and with positive autofluorescence detection in the lesion area before surgery.

Exclusion criteria

Exclusion criteria: Patients who are unwilling to accept this study for various reasons; Patients who cannot undergo pathological examination due to various studies; Patients with incomplete clinical photos or pathological results, or those with negative autofluorescence tests.

Design outcomes

Primary

MeasureTime frame
The accuracy of the judgment results;

Countries

China

Contacts

Public ContactHan Ying

Peking University Hospital of Stomatology

13683375487@163.com+86 10 8219 5226

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026